CRA International (CRAI) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $2.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.37%. A quarter ago, it was expected that this consulting firm would post earnings of $1.8 per share when it actually produced earnings of $2.06, delivering a surprise of +14.44%.Over the last four quarters, th ...

Viatris (VTRS) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.62%. A quarter ago, it was expected that this generic drugmaker would post earnings of $0.63 per share when it actually produced earnings of $0.67, delivering a surprise of +6.35%.Over the last four quarters, the compan ...

Millicom International Cellular SA (TIGO) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +42.86%. A quarter ago, it was expected that this company would post earnings of $0.55 per share when it actually produced earnings of $0.34, delivering a surprise of -38.18%.Over the last four qua ...

分组1 - ACI Worldwide reported quarterly earnings of $0.9 per share, missing the Zacks Consensus Estimate of $1.05 per share, and down from $1.08 per share a year ago, representing an earnings surprise of -14.29% [1] - The company posted revenues of $481.6 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.82%, and up from $453.04 million year-over-year [2] - ACI Worldwide has surpassed consensus revenue estimates four times over the last four quarters [2] 分组2 - ACI Worldwide shares have declined approximately 13.2% since the beginning of the year, while the S&P 500 has gained 1.5% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The estimate revisions trend for ACI Worldwide was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] 分组3 - The current consensus EPS estimate for the upcoming quarter is $0.34 on revenues of $402.2 million, and for the current fiscal year, it is $3.41 on revenues of $1.87 billion [7] - The Computer - Software industry, to which ACI Worldwide belongs, is currently in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]

Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.57%. A quarter ago, it was expected that this company would post earnings of $0.11 per share when it actually produced earnings of $0.14, delivering a surprise of +27.27%.Over the last four quarters, the company ...

Core Viewpoint - TAL Education (TAL) shows potential for significant upside, with a mean price target of $15.85 indicating a 44.6% increase from its current price of $10.96 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $11.54 to a high of $18.00, with a standard deviation of $2.19, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 5.3% increase, while the highest suggests a 64.2% upside [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement [2][9] Analyst Sentiment - Analysts are increasingly optimistic about TAL's earnings prospects, as evidenced by a trend of upward revisions in EPS estimates [11] - Over the past 30 days, three estimates have been revised higher, leading to a 42.5% increase in the Zacks Consensus Estimate for the current year [12] - TAL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be prudent, as analysts' ability to set accurate targets has been questioned [3][7] - Analysts often set optimistic targets due to business incentives, which can lead to inflated price expectations [8] - While price targets should not be ignored, they should be approached with skepticism and not be the sole basis for investment decisions [10]

分组1 - BridgeBio Pharma reported a quarterly loss of $1 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.75, and compared to a loss of $1.31 per share a year ago, indicating a surprise of -34.05% [1] - The company posted revenues of $154.18 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.77%, and showing a significant increase from year-ago revenues of $5.88 million [2] - Over the last four quarters, BridgeBio Pharma has surpassed consensus revenue estimates four times, but has only exceeded consensus EPS estimates once [2] 分组2 - The stock has underperformed the market, losing about 11.2% since the beginning of the year, while the S&P 500 has declined by only 0.1% [3] - The current consensus EPS estimate for the coming quarter is -$0.64 on revenues of $173.51 million, and for the current fiscal year, it is -$1.79 on revenues of $900.31 million [7] - The Zacks Industry Rank for Medical - Generic Drugs is currently in the bottom 34% of over 250 Zacks industries, indicating potential challenges for stocks in this sector [8]

A10 Networks (ATEN) closed the last trading session at $18.94, gaining 6.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.4 indicates a 28.8% upside potential.The average comprises five short-term price targets ranging from a low of $22.00 to a high of $28.00, with a standard deviation of $2.3. While the lowest estimate indicates an increase of 16.2% from the current price le ...

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -19.81%. A quarter ago, it was expected that this company would post earnings of $0.24 per share when it actually produced earnings of $0.22, delivering a surprise of -8.33%.Over the last four quarters, the compa ...

First Watch Restaurant Group, Inc. (FWRG) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +209.68%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.05, delivering a surprise of -37.5%.Over the last four q ...